-
1
-
-
0035908632
-
C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus
-
Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001; 286: 327-334. (Pubitemid 32656163)
-
(2001)
Journal of the American Medical Association
, vol.286
, Issue.3
, pp. 327-334
-
-
Pradhan, A.D.1
Manson, J.E.2
Rifai, N.3
Buring, J.E.4
Ridker, P.M.5
-
2
-
-
0036312978
-
C-reactive protein is an independent predictor of risk for the development of diabetes in the west of Scotland coronary prevention study
-
Freeman DJ, Norrie J, Caslake MJ, et al. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes 2002; 51: 1596-1600. (Pubitemid 34826630)
-
(2002)
Diabetes
, vol.51
, Issue.5
, pp. 1596-1600
-
-
Freeman, D.J.1
Norrie, J.2
Caslake, M.J.3
Gaw, A.4
Ford, I.5
Lowe, G.D.O.6
O'Reilly, D.S.J.7
Packard, C.J.8
Sattar, N.9
-
3
-
-
33845298023
-
Diabetes, inflammation, and functional decline in older adults: Findings from the health, aging and body composition (ABC) study
-
DOI 10.2337/dc06-0245
-
Figaro MK, Kritchevsky SB, Resnick HE, et al. Findings from the health, aging and body composition (ABC) study: diabetes, inflammation, and functional decline in older adults. Diabetes Care 2006; 29: 2039-2045. (Pubitemid 44871184)
-
(2006)
Diabetes Care
, vol.29
, Issue.9
, pp. 2039-2045
-
-
Figaro, M.K.1
Kritchevsky, S.B.2
Resnick, H.E.3
Shorr, R.I.4
Butler, J.5
Shintani, A.6
Penninx, B.W.7
Simonsick, E.M.8
Goodpaster, B.H.9
Newman, A.B.10
Schwartz, A.V.11
Harris, T.B.12
-
4
-
-
26244441533
-
Oxidant stress, inflammation and atherogenesis
-
Davi G, Falco A. Oxidant stress, inflammation and atherogenesis:. Lupus 2005; 14: 760-764.
-
(2005)
Lupus
, vol.14
, pp. 760-764
-
-
Davi, G.1
Falco, A.2
-
5
-
-
0036311636
-
Assessing the impact of complications on the costs of Type II diabetes
-
Williams R, Van Gaal L, Lucioni C. CODE-2 Advisory Board. Assessing the impact of complications on the costs of type II diabetes. Diabetologia 2002; 45: S13-S17. (Pubitemid 34762209)
-
(2002)
Diabetologia
, vol.45
, Issue.6
-
-
Williams, R.1
Van Gaal, L.2
Lucioni, C.3
-
6
-
-
0003775058
-
-
American Heart Association. American Heart Association: Dallas, TX
-
American Heart Association. Heart Disease and Stroke Statistical Update. American Heart Association: Dallas, TX, 2004.
-
(2004)
Heart Disease and Stroke Statistical Update
-
-
-
7
-
-
0034455878
-
Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes
-
DOI 10.1210/jc.85.8.2970
-
Mohanty P, Hamouda W, Garg R, Aljada A, Ghanim H, Dandona P. Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J Clin Endocrinol Metab 2000; 85: 2970-2973. (Pubitemid 32269184)
-
(2000)
Journal of Clinical Endocrinology and Metabolism
, vol.85
, Issue.8
, pp. 2970-2973
-
-
Mohanty, P.1
Hamouda, W.2
Garg, R.3
Aljada, A.4
Ghanim, H.5
Dandona, P.6
-
8
-
-
0033372640
-
Reactive oxygen species in essential hypertension and non-insulin- Dependent diabetes mellitus
-
DOI 10.1016/S0895-7061(99)00129-6, PII S0895706199001296
-
Orie NN, Zidek W, Tepel M. Reactive oxygen species in essential hypertension and non-insulin-dependent diabetes mellitus. Am J Hypertens 1999; 12: 1169-1174. (Pubitemid 30029278)
-
(1999)
American Journal of Hypertension
, vol.12
, Issue.12 I
, pp. 1169-1174
-
-
Orie, N.N.1
Zidek, W.2
Tepel, M.3
-
9
-
-
0032589599
-
Antioxidants, NFkappaB activation, and diabetogenesis
-
Ho E, Bray TM. Antioxidants, NFkappaB activation, and diabetogenesis. Proc Soc Exp Biol Med 1999; 222: 205-213.
-
(1999)
Proc Soc Exp Biol Med
, vol.222
, pp. 205-213
-
-
Ho, E.1
Bray, T.M.2
-
10
-
-
33846931618
-
Proinflammatory Effects of Glucose and Anti-Inflammatory Effect of Insulin: Relevance to Cardiovascular Disease
-
DOI 10.1016/j.amjcard.2006.11.003, PII S0002914906021941, The Cardiologist's Role in Improving Glucose Control and Global Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus
-
Dandona P, Chaudhuri A, Ghanim H, Mohanty P. Proinflammatory effects of glucose and anti-inflammatory effect of insulin: relevance to cardiovascular disease. Am J Cardiol 2007; 99: (Suppl): 15B-26B. (Pubitemid 46239948)
-
(2007)
American Journal of Cardiology
, vol.99
, Issue.4 SUPPL.
, pp. 15-26
-
-
Dandona, P.1
Chaudhuri, A.2
Ghanim, H.3
Mohanty, P.4
-
11
-
-
1842453995
-
Differential effects of glucose and alcohol on reactive oxygen species generation and intranuclear nuclear factor-κB in mononuclear cells
-
DOI 10.1016/j.metabol.2003.10.013
-
Dhindsa S, Tripathy D, Mohanty P, et al. Differential effects of glucose and alcohol on reactive oxygen species generation and intranuclear nuclear factor-κB in mononuclear cells. Metabolism 2004; 53: 330-334. (Pubitemid 38684693)
-
(2004)
Metabolism: Clinical and Experimental
, vol.53
, Issue.3
, pp. 330-334
-
-
Dhindsa, S.1
Tripathy, D.2
Mohanty, P.3
Ghanim, H.4
Syed, T.5
Aljada, A.6
Dandona, P.7
-
12
-
-
33747049210
-
Glucose ingestion induces an increase in intranuclear nuclear factor kappaB, a fall in cellular inhibitor kappaB, and an increase in tumor necrosis factor alpha messenger RNA by mononuclear cells in healthy human subjects
-
DOI 10.1016/j.metabol.2006.04.016, PII S0026049506001582
-
Aljada A, Friedman J, Ghanim H, et al. Glucose ingestion induces an increase in intranuclear nuclear factor kappaB, a fall in cellular inhibitor kappaB, and an increase in tumor necrosis factor alpha messenger RNA by mononuclear cells in healthy human subjects. Metabolism 2006; 55: 1177-1185. (Pubitemid 44215936)
-
(2006)
Metabolism: Clinical and Experimental
, vol.55
, Issue.9
, pp. 1177-1185
-
-
Aljada, A.1
Friedman, J.2
Ghanim, H.3
Mohanty, P.4
Hofmeyer, D.5
Chaudhuri, A.6
Dandona, P.7
-
13
-
-
0035411587
-
Role of the NF-kappaB pathway in the pathogenesis of human disease states
-
Yamamoto Y, Gaynor RB. Role of the NF-kappaB pathway in the pathogenesis of human disease states. Curr Mol Med 2001; 1: 287-296. (Pubitemid 33773312)
-
(2001)
Current Molecular Medicine
, vol.1
, Issue.3
, pp. 287-296
-
-
Yamamoto, Y.1
Gaynor, R.B.2
-
14
-
-
0032960891
-
Vascular endothelial growth factor activates nuclear factor-kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells
-
DOI 10.2337/diabetes.48.5.1131
-
Marumo T, Schini-Kerth VB, Busse R. Vascular endothelial growth factor activates nuclear factor-kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells. Diabetes 1999; 48: 1131-1137. (Pubitemid 29226362)
-
(1999)
Diabetes
, vol.48
, Issue.5
, pp. 1131-1137
-
-
Marumo, T.1
Schini-Kerth, V.B.2
Busse, R.3
-
15
-
-
33846025430
-
Persistent Activation of Nuclear Factor Kappa-B Signaling Pathway in Patients with Unstable Angina and Elevated Levels of C-Reactive Protein. Evidence for a Direct Proinflammatory Effect of Azide and Lipopolysaccharide- Free C-Reactive Protein on Human Monocytes Via Nuclear Factor Kappa-B Activation
-
DOI 10.1016/j.jacc.2006.07.071, PII S0735109706025010
-
Liuzzo G, Santamaria M, Biasucci LM, et al. Persistent activation of nuclear factor kappa-B signaling pathway in patients with unstable angina and elevated levels of C-reactive protein evidence for a direct proinflammatory effect of azide and lipopolysaccharide-free C-reactive protein on human monocytes via nuclear factor kappa-B activation. J Am Coll Cardiol 2007; 49: 185-194. (Pubitemid 46054391)
-
(2007)
Journal of the American College of Cardiology
, vol.49
, Issue.2
, pp. 185-194
-
-
Liuzzo, G.1
Santamaria, M.2
Biasucci, L.M.3
Narducci, M.4
Colafrancesco, V.5
Porto, A.6
Brugaletta, S.7
Pinnelli, M.8
Rizzello, V.9
Maseri, A.10
Crea, F.11
-
16
-
-
23844516988
-
Regulation of basal and induced expression of C-reactive protein through an overlapping element for OCT-1 and NF-kappaB on the proximal promoter
-
Voleti B, Agrawal A. Regulation of basal and induced expression of C-reactive protein through an overlapping element for OCT-1 and NF-kappaB on the proximal promoter. J Immunol 2005; 175: 3386-3390. (Pubitemid 41170561)
-
(2005)
Journal of Immunology
, vol.175
, Issue.5
, pp. 3386-3390
-
-
Voleti, B.1
Agrawal, A.2
-
17
-
-
0037394635
-
Overexpressed nuclear factor-kappaB can participate in endogenous C-reactive protein induction, and enhances the effects of C/EBPbeta and signal transducer and activator of transcription-3
-
DOI 10.1046/j.1365-2567.2003.01608.x
-
Agrawal A, Cha-Molstad H, Samols D, Kushner I. Overexpressed nuclear factor-kappaB can participate in endogenous C-reactive protein induction, and enhances the effects of C/EBPbeta and signal transducer and activator of transcription-3. Immunology 2003; 108: 539-547. (Pubitemid 36469692)
-
(2003)
Immunology
, vol.108
, Issue.4
, pp. 539-547
-
-
Agrawal, A.1
Cha-Molstad, H.2
Samols, D.3
Kushner, I.4
-
18
-
-
0028899385
-
Insulin attenuates norepinephrine-induced venoconstriction: An ultrasonographic study
-
Grover A, Padginton C, Wilson MF, Sung BH, Izzo JL, Dandona P Jr. Insulin attenuates norepinephrine-induced venoconstriction: an ultrasonographic study. Hypertension 1995; 25: 779-784.
-
(1995)
Hypertension
, vol.25
, pp. 779-784
-
-
Grover, A.1
Padginton, C.2
Wilson, M.F.3
Sung, B.H.4
Izzo, J.L.5
Dandona Jr., P.6
-
19
-
-
0028030813
-
Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. a novel action of insulin to increase nitric oxide release
-
Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD. Insulinmediated skeletal muscle vasodilation is nitric oxide dependent: a novel action of insulin to increase nitric oxide release. J Clin Invest 1994; 94: 1172-1179. (Pubitemid 24286460)
-
(1994)
Journal of Clinical Investigation
, vol.94
, Issue.3
, pp. 1172-1179
-
-
Steinberg, H.O.1
Brechtel, G.2
Johnson, A.3
Fineberg, N.4
Baron, A.D.5
-
20
-
-
0027931376
-
Insulin increases guanosine-3',5'-cyclic monophosphate in human platelets: A mechanism involved in the insulin anti-aggregating effect
-
Trovati M, Massucco P, Mattiello L, Mularoni E, Cavalot F, Anfossi G. Insulin increases guanosine-3′, 5′-cyclic monophosphate in human platelets: a mechanism involved in the insulin anti-aggregating effect. Diabetes 1994; 43: 1015-1019. (Pubitemid 24230706)
-
(1994)
Diabetes
, vol.43
, Issue.8
, pp. 1015-1019
-
-
Trovati, M.1
Massucco, P.2
Mattiello, L.3
Mularoni, E.4
Cavalot, F.5
Anfossi, G.6
-
21
-
-
15444357865
-
Insulin stimulates nitric oxide synthesis in human platelets and, through nitric oxide, increases platelet concentrations of both guanosine- 3',5'-cyclic monophosphate and adenosine-3',5'-cyclic monophosphate
-
Trovati M, Anfossi G, Massucco P, et al. Insulin stimulates nitric oxide synthesis in human platelets and, through nitric oxide, increases platelet concentrations of both guanosine-3′, 5′-cyclic monophosphate and adenosine-3′, 5′-cyclic monophosphate. Diabetes 1997; 46: 742-749. (Pubitemid 27188249)
-
(1997)
Diabetes
, vol.46
, Issue.5
, pp. 742-749
-
-
Trovati, M.1
Anfossi, G.2
Massucco, P.3
Mattiello, L.4
Costamagna, C.5
Piretto, V.6
Mularoni, E.7
Cavalot, F.8
Bosia, A.9
Ghigo, D.10
-
22
-
-
0034746443
-
Insulin inhibits NFkappa B and MCP-1 expression in human aortic endothelial cells
-
DOI 10.1210/jc.86.1.450
-
Aljada A, Ghanim H, Saadeh R, Dandona P. Insulin inhibits NFkappa B and MCP-1 expression in human aortic endothelial cells. J Clin Endocrinol Metab 2001; 86: 451-453. (Pubitemid 32109834)
-
(2001)
Journal of Clinical Endocrinology and Metabolism
, vol.86
, Issue.1
, pp. 450-453
-
-
Aljada, A.1
Ghanim, H.2
Saadeh, R.3
Dandona, P.4
-
23
-
-
0034915177
-
Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: Evidence for an anti-inflammatory effect?
-
DOI 10.1210/jc.86.7.3257
-
Dandona P, Aljada A, Mohanty P, et al. Insulin inhibits intranuclear nuclear factor kappaB and stimulates I kappaB in mononuclear cells in obese subjects: evidence for an antiinflammatory effects? J Clin Endocrinol Metab 2001; 86: 3257-3265. (Pubitemid 32674120)
-
(2001)
Journal of Clinical Endocrinology and Metabolism
, vol.86
, Issue.7
, pp. 3257-3265
-
-
Dandona, P.1
Aljada, A.2
Mohanty, P.3
Ghanim, H.4
Hamouda, W.5
Assian, E.6
Ahmad, S.7
-
24
-
-
4344645520
-
Insulin attenuates the systemic inflammatory response in endotoxemic rats
-
DOI 10.1210/en.2004-0592
-
Jeschke MG, Klein D, Bolder U, Einspanier R. Insulin attenuates the systemic inflammatory response in endotoxemic rats. Endocrinology 2004; 145: 4084-4093. (Pubitemid 39120556)
-
(2004)
Endocrinology
, vol.145
, Issue.9
, pp. 4084-4093
-
-
Jeschke, M.G.1
Klein, D.2
Bolder, U.3
Einspanier, R.4
-
25
-
-
34248381321
-
Effects of insulin on hepatic inflammation induced by ethanol and burn injury in a murine model of critical illness
-
Emanuele MA, Emanuele NV, Gamelli RL, Kovacs EJ, LaPaglia N. Effects of insulin on hepatic inflammation induced by ethanol and burn injury in a murine model of critical illness. J Burn Care Res 2007; 28: 490-499.
-
(2007)
J Burn Care Res
, vol.28
, pp. 490-499
-
-
Emanuele, M.A.1
Emanuele, N.V.2
Gamelli, R.L.3
Kovacs, E.J.4
Lapaglia, N.5
-
26
-
-
26444588755
-
Glucose, insulin and potassium applied as perioperative hyperinsulinaemic normoglycaemic clamp: Effects on inflammatory response during coronary artery surgery
-
DOI 10.1093/bja/aei220
-
Visser L, Zuurbier CJ, Hoek FJ, et al. Glucose, insulin and potassium applied as perioperative hyperinsulinaemic normoglycaemic clamp: effects on inflammatory response during coronary artery surgery. Br J Anaesth 2005; 95: 448-457. (Pubitemid 41418737)
-
(2005)
British Journal of Anaesthesia
, vol.95
, Issue.4
, pp. 448-457
-
-
Visser, L.1
Zuurbier, C.J.2
Hoek, F.J.3
Opmeer, B.C.4
De Jonge, E.5
De Mol, B.A.J.M.6
Van Wezel, H.B.7
-
27
-
-
10744232591
-
Anti-Inflammatory and Profibrinolytic Effect of Insulin in Acute ST-Segment-Elevation Myocardial Infarction
-
DOI 10.1161/01.CIR.0000116762.77804.FC
-
Chaudhuri A, Janicke D, Wilson MF, et al. Anti-inflammatory and profibrinolytic effect of insulin in acute ST-segment-elevation myocardial infarction. Circulation 2004; 109: 849-854. (Pubitemid 38252736)
-
(2004)
Circulation
, vol.109
, Issue.7
, pp. 849-854
-
-
Chaudhuri, A.1
Janicke, D.2
Wilson, M.F.3
Tripathy, D.4
Garg, R.5
Bandyopadhyay, A.6
Calieri, J.7
Hoffmeyer, D.8
Syed, T.9
Ghanim, H.10
Aljada, A.11
Dandona, P.12
-
28
-
-
3442899889
-
Effect of an intensive glucose management protocol on the mortality of critically ill adult patients
-
Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 2004; 79: 992-1000.
-
(2004)
Mayo Clin Proc
, vol.79
, pp. 992-1000
-
-
Krinsley, J.S.1
-
29
-
-
0037341759
-
Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels
-
DOI 10.1210/jc.2002-021478
-
Hansen TK, Thiel S, Wouters PJ, Christiansen JS, Van den Berghe G. Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab 2003; 88: 1082-1088. (Pubitemid 36337759)
-
(2003)
Journal of Clinical Endocrinology and Metabolism
, vol.88
, Issue.3
, pp. 1082-1088
-
-
Hansen, T.K.1
Thiel, S.2
Wouters, P.J.3
Christiansen, J.S.4
Van Den Berghe, G.5
-
30
-
-
0036433019
-
C-reactive protein is more strongly related to post-glucose load glucose than to fasting glucose in non-diabetic subjects; the Insulin Resistance Atherosclerosis Study
-
DOI 10.1046/j.1464-5491.2002.00824.x
-
Festa A, D'Agostino R Jr, Tracy RP, Haffner SM. C-reactive protein is more strongly related to post-glucose load glucose than to fasting glucose in non-diabetic subjects; the Insulin Resistance Atherosclerosis Study. Diabetic Medicine 2002; 19: 939-943. (Pubitemid 35356920)
-
(2002)
Diabetic Medicine
, vol.19
, Issue.11
, pp. 939-943
-
-
Festa, A.1
D'Agostino Jr., R.2
Tracy, R.P.3
Haffner, S.M.4
-
31
-
-
1842334456
-
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
-
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183-1197. (Pubitemid 27274286)
-
(1997)
Diabetes Care
, vol.20
, Issue.7
, pp. 1183-1197
-
-
Kahn, R.1
-
32
-
-
3042852246
-
Initiation of insulin therapy reduces serum concentrations of high-sensitivity C-reactive protein in patients with type 2 diabetes
-
DOI 10.1016/j.metabol.2004.01.003, PII S0026049504000733
-
Takebayashi K, Aso Y, Inukai T. Initiation of insulin therapy reduces serum concentrations of high-sensitivity C-reactive protein in patients with type 2 diabetes. Metabolism 2004; 53: 693-699. (Pubitemid 38880897)
-
(2004)
Metabolism: Clinical and Experimental
, vol.53
, Issue.6
, pp. 693-699
-
-
Takebayashi, K.1
Aso, Y.2
Inukai, T.3
-
33
-
-
0036964978
-
Insulin inhibits the pro-inflammatory transcription factor early growth response gene-1 (Egr)-1 expression in mononuclear cells (MNC) and reduces plasma tissue factor (TF) and plasminogen activator inhibitor-1 (PAI-1) concentrations
-
DOI 10.1210/jc.87.3.1419
-
Aljada A, Ghanim H, Mohanty P, Kapur N, Dandona P. Insulin inhibits the pro-inflammatory transcription factor early growth response gene-1 (Egr)-1 expression in mononuclear cells (MNC) and reduces plasma tissue factor (TF) and plasminogen activator inhibitor-1 (PAI-1) concentrations. J Clin Endocrinol Metab 2002; 87: 1419-1422. (Pubitemid 36121118)
-
(2002)
Journal of Clinical Endocrinology and Metabolism
, vol.87
, Issue.3
, pp. 1419-1422
-
-
Aljada, A.1
Ghanim, H.2
Mohanty, P.3
Kapur, N.4
Dandona, P.5
-
34
-
-
0034915177
-
Insulin inhibits intranuclear nuclear factor κB and stimulates IκB in mononuclear cells in obese subjects: Evidence for an anti-inflammatory effect?
-
DOI 10.1210/jc.86.7.3257
-
Dandona P, Aljada A, Mohanty P, et al. Insulin inhibits intranuclear nuclear factor κB and stimulates IκB in mononuclear cells in obese subjects: evidence for an antiinflammatory effect? J Clin Endocrinol Metab 2001; 86: 3257-3265. (Pubitemid 32674120)
-
(2001)
Journal of Clinical Endocrinology and Metabolism
, vol.86
, Issue.7
, pp. 3257-3265
-
-
Dandona, P.1
Aljada, A.2
Mohanty, P.3
Ghanim, H.4
Hamouda, W.5
Assian, E.6
Ahmad, S.7
-
35
-
-
38149040839
-
Asymmetric dimethylarginine, inflammatory and metabolic parameters in women with polycystic ovary syndrome before and after metformin treatment
-
Heutling D, Schulz H, Nickel I, et al. Asymmetric dimethylarginine, inflammatory and metabolic parameters in women with polycystic ovary syndrome before and after metformin treatment. J Clin Endocrin Metab 2008; 93: 82-90.
-
(2008)
J Clin Endocrin Metab
, vol.93
, pp. 82-90
-
-
Heutling, D.1
Schulz, H.2
Nickel, I.3
-
36
-
-
34347387742
-
Both slow-release and regular-form metformin improve glycemic control without altering plasma visfatin level in patients with type 2 diabetes mellitus
-
Hsieh CH, He CT, Lee CH, Wu LY, Hung YJ. Both slow-release and regular-form metformin improve glycemic control without altering plasma visfatin level in patients with type 2 diabetes mellitus. Metabolism 2007; 56: 1087-1092.
-
(2007)
Metabolism
, vol.56
, pp. 1087-1092
-
-
Hsieh, C.H.1
He, C.T.2
Lee, C.H.3
Wu, L.Y.4
Hung, Y.J.5
-
37
-
-
33846205131
-
Effects of rosiglitazone and metformin on inflammatory markers and adipokines: Decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus
-
Kim HJ, Kang ES, Kim DJ, et al. Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus. Clin Endocrinol 2007; 66: 282-289.
-
(2007)
Clin Endocrinol
, vol.66
, pp. 282-289
-
-
Kim, H.J.1
Kang, E.S.2
Kim, D.J.3
-
38
-
-
33847403059
-
A randomized trial of the effects of rosiglitazone and metformin on inflammation and subclinical atherosclerosis in patients with type 2 diabetes
-
Stocker DJ, Taylor AJ, Langley RW, Jezior MR, Vigersky RA. A randomized trial of the effects of rosiglitazone and metformin on inflammation and subclinical atherosclerosis in patients with type 2 diabetes. Am Heart J 2007; 153: 445-e1-445-e6.
-
(2007)
Am Heart J
, vol.153
-
-
Stocker, D.J.1
Taylor, A.J.2
Langley, R.W.3
Jezior, M.R.4
Vigersky, R.A.5
-
39
-
-
33847041377
-
Comparison of the effects of pioglitazone and metformin on insulin resistance and hormonal markers in patients with impaired glucose tolerance and early diabetes
-
DOI 10.1291/hypres.30.23
-
Eguchi K, Tomizawa H, Ishikawa J, et al. Comparison of the effects of pioglitazone and metformin on insulin resistance and hormonal markers in patients with impaired glucose tolerance and early diabetes. Hypertens Res 2007; 30: 23-30. (Pubitemid 46259795)
-
(2007)
Hypertension Research
, vol.30
, Issue.1
, pp. 23-30
-
-
Eguchi, K.1
Tomizawa, H.2
Ishikawa, J.3
Hoshide, S.4
Numao, T.5
Fukuda, T.6
Shimada, K.7
Kario, K.8
-
40
-
-
19944433033
-
Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: A randomized, placebo-controlled trial
-
DOI 10.1111/j.1365-2796.2004.01420.x
-
De Jager J, Kooy A, Lehert P, et al. Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial. J Intern Med 2005; 257: 100-109. (Pubitemid 40129131)
-
(2005)
Journal of Internal Medicine
, vol.257
, Issue.1
, pp. 100-109
-
-
De Jager, J.1
Kooy, A.2
Lehert, Ph.3
Bets, D.4
Wulffele, M.G.5
Teerlink, T.6
Scheffer, P.G.7
Schalkwijk, C.G.8
Donker, A.J.M.9
Stehouwer, C.D.A.10
-
41
-
-
0036517747
-
Differential effects of metformin and troglitazone on cardiovascular risk factors in patients with type 2 diabetes
-
DOI 10.2337/diacare.25.3.542
-
Chu NV, Kong AP, Kim DD, et al. Differential effects of metformin and troglitazone on cardiovascular risk factors in patients with type 2 diabetes. Diabetes Care 2002; 25: 542-549. (Pubitemid 41103350)
-
(2002)
Diabetes Care
, vol.25
, Issue.3
, pp. 542-549
-
-
Chu, N.V.1
Kong, A.P.S.2
Kim, D.D.3
Armstrong, D.4
Baxi, S.5
Deutsch, R.6
Caulfield, M.7
Mudaliar, S.R.8
Reitz, R.9
Henry, R.R.10
Reaven, P.D.11
-
42
-
-
0038064504
-
Effect of metformin and sulfonylurea on C-reactive protein level in well-controlled type 2 diabetics with metabolic syndrome
-
Akbar DH. Effect of metformin and sulfonylurea on C-reactive protein level in well-controlled type 2 diabetics with metabolic syndrome. Endocrine 2003; 20: 215-218.
-
(2003)
Endocrine
, vol.20
, pp. 215-218
-
-
Akbar, D.H.1
-
43
-
-
0038542983
-
Elevated concentrations of C-reactive protein in subjects with Type 2 diabetes mellitus are moderately influenced by glycemic control
-
Rodríguez-Morán M, Guerrero-Romero F. Elevated concentrations of C-reactive protein in subjects with type 2 diabetes mellitus are moderately influenced by glycemic control. J Endocrinol Invest 2003; 26: 216-221. (Pubitemid 36681740)
-
(2003)
Journal of Endocrinological Investigation
, vol.26
, Issue.3
, pp. 216-221
-
-
Rodriguez-Moran, M.1
Guerrero-Romero, F.2
-
44
-
-
24044543259
-
Metformin reduces C-reactive protein but not complement factor C3 in overweight patients with Type 2 diabetes mellitus
-
Carter AM, Bennett CE, Bostock JA, Grant PJ. Metformin reduces C-reactive protein but not complement factor C3 in overweight patients with Type 2 diabetes mellitus. Diabet Med 2005; 22: 1282-1284.
-
(2005)
Diabet Med
, vol.22
, pp. 1282-1284
-
-
Carter, A.M.1
Bennett, C.E.2
Bostock, J.A.3
Grant, P.J.4
-
45
-
-
59549102756
-
Exercise as a mean to control low-grade systemic inflammation
-
ID109502(1-6)
-
Mathur N, Pedersen BK. Exercise as a mean to control low-grade systemic inflammation. Mediators Inflamm 2008; ID109502(1-6).
-
(2008)
Mediators Inflamm
-
-
Mathur, N.1
Pedersen, B.K.2
-
46
-
-
33847646382
-
Exercise reduces resistin and inflammatory cytokines in patients with type 2 diabetes
-
DOI 10.2337/dc06-1149
-
Kadoglou NP, Perrea D, Iliadis F, Angelopoulou N, Liapis C, Alevizos M. Exercise reduces resistin and inflammatory cytokines in patients with type 2 diabetes. Diabetes Care 2007; 30: 719-721. (Pubitemid 46354360)
-
(2007)
Diabetes Care
, vol.30
, Issue.3
, pp. 719-721
-
-
Kadoglou, N.P.1
Perrea, D.2
Iliadis, F.3
Angelopoulou, N.4
Liapis, C.5
Alevizos, M.6
-
47
-
-
36649035989
-
The anti-inflammatory effects of exercise training in patients with type 2 diabetes mellitus
-
DOI 10.1097/HJR.0b013e3282efaf50, PII 0014983120071200000019
-
Kadoglou NP, Iliadis F, Angelopoulou N, et al. The antiinflammatory effects of exercise training in patients with type 2 diabetes mellitus. Eur J Cardiovasc Prev Rehabil 2007; 14: 837-843. (Pubitemid 350197015)
-
(2007)
European Journal of Cardiovascular Prevention and Rehabilitation
, vol.14
, Issue.6
, pp. 837-843
-
-
Kadoglou, N.P.E.1
Iliadis, F.2
Angelopoulou, N.3
Perrea, D.4
Ampatzidis, G.5
Liapis, C.D.6
Alevizos, M.7
-
48
-
-
33845424579
-
Effect of weight loss and nutritional intervention on arterial stiffness in type 2 diabetes
-
DOI 10.2337/dc06-0665
-
Barinas-Mitchell E, Kuller LH, Sutton-Tyrrell K, et al. Effect of weight loss and nutritional intervention on arterial stiffness in type 2 diabetes. Diabetes Care 2006; 29: 2218-2222. (Pubitemid 44899855)
-
(2006)
Diabetes Care
, vol.29
, Issue.10
, pp. 2218-2222
-
-
Barinas-Mitchell, E.1
Kuller, L.H.2
Sutton-Tyrrell, K.3
Hegazi, R.4
Harper, P.5
Mancino, J.6
Kelley, D.E.7
-
49
-
-
0033821518
-
The influence of improved glycaemic control with insulin and sulphonylureas on acute phase and endothelial markers in Type II diabetic subjects
-
DOI 10.1007/s001250051500
-
Yudkin JS, Panahloo A, Stehouwer C, et al. The influence of improved glycaemic control with insulin and sulphonylureas on acute phase and endothelial markers in type II diabetic subjects. Diabetologia 2000; 43: 1099-1106. (Pubitemid 30702932)
-
(2000)
Diabetologia
, vol.43
, Issue.9
, pp. 1099-1106
-
-
Yudkin, J.S.1
Panahloo, A.2
Stehouwer, C.3
Emeis, J.J.4
Bulmer, K.5
Mohamed-Ali, V.6
Denver, A.E.7
-
50
-
-
0032923669
-
C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984-1992
-
Koenig W, Sund M, Frohlich M, et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984-1992. Circulation 1999; 99: 237-242.
-
(1999)
Circulation
, vol.99
, pp. 237-242
-
-
Koenig, W.1
Sund, M.2
Frohlich, M.3
-
51
-
-
0030956673
-
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
-
DOI 10.1056/NEJM199704033361401
-
Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin and the risks of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973-979. (Pubitemid 27152782)
-
(1997)
New England Journal of Medicine
, vol.336
, Issue.14
, pp. 973-979
-
-
Ridker, P.M.1
Cushman, M.2
Stampfer, M.J.3
Tracy, R.P.4
Hennekens, C.H.5
-
52
-
-
0034704893
-
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
-
DOI 10.1056/NEJM200003233421202
-
Ridker PMJ, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342: 836-843. (Pubitemid 30165206)
-
(2000)
New England Journal of Medicine
, vol.342
, Issue.12
, pp. 836-843
-
-
Ridker, P.M.1
Hennekens, C.H.2
Buring, J.E.3
Rifai, N.4
|